Carson Wealth (CWM LLC)’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.22M Sell
17,891
-414
-2% -$29.3K ﹤0.01% 1435
2025
Q4
$1.39M Buy
18,305
+1,142
+7% +$83K ﹤0.01% 1323
2025
Q3
$1.05M Sell
17,163
-692
-4% -$36K ﹤0.01% 1376
2025
Q2
$872K Buy
17,855
+99
+0.6% +$4.7K ﹤0.01% 1314
2025
Q1
$905K Buy
17,756
+14,139
+391% +$706K ﹤0.01% 1186
2024
Q4
$163K Buy
3,617
+930
+35% +$39.8K ﹤0.01% 1963
2024
Q3
$100K Buy
2,687
+2,096
+355% +$70.2K ﹤0.01% 2194
2024
Q2
$18K Buy
591
+543
+1,131% +$17.6K ﹤0.01% 3191
2024
Q1
$1K Buy
48
+14
+41% +$392 ﹤0.01% 4196
2023
Q4
$1K Sell
34
-101
-75% -$2.31K ﹤0.01% 4020
2023
Q3
$3K Sell
135
-927
-87% -$34.5K ﹤0.01% 3696
2023
Q2
$43K Buy
1,062
+85
+9% +$4.16K ﹤0.01% 2099
2023
Q1
$47K Hold
977
﹤0.01% 1910
2022
Q4
$37K Buy
977
+963
+6,879% +$40K ﹤0.01% 1938
2022
Q3
$1K Hold
14
﹤0.01% 3728
2022
Q2
$1K Sell
14
-62
-82% -$2.17K ﹤0.01% 3607
2022
Q1
$3K Sell
76
-17
-18% -$655 ﹤0.01% 3066
2021
Q4
$4K Buy
+93
New +$3.56K ﹤0.01% 2868

Other funds holding PTCT

Carson Wealth (CWM LLC)'s PTCT Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its PTC Therapeutics (PTCT) stake by 2.3% in Q1 2026, selling an estimated $29.3K and leaving 17,891 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1435.

Carson Wealth (CWM LLC) first reported a position in PTCT in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.39M in Q4 2025. 351 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Carson Wealth (CWM LLC) held 17,891 shares of PTC Therapeutics worth $1.22M as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 414 PTC Therapeutics shares in Q1 2026, an estimated $29.3K.
  • PTC Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1435 holding.
  • Carson Wealth (CWM LLC) first reported a position in PTC Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • Carson Wealth (CWM LLC)'s PTC Therapeutics position peaked at $1.39M in Q4 2025.
  • 351 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.